A number of institutional investors are proving the health sciences venture capital space holds significant potential for Australian investors, with funding from the likes of QIC and Hostplus driving major pharmaceutical developments. https://www.financialstandard.com.au/feed/latest?story=88942794 en-AU Copyright 2026 Financial Standard 5